Healthcare provider profile · identity verified

Peter C Szekely, MD

Internal Medicine · MISSOULA, MT · NPI 1346294998

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	982	291
Amlodipine Besylate	Amlodipine Besylate	712	203
Levothyroxine Sodium	Levothyroxine Sodium	651	184
Losartan Potassium	Losartan Potassium	622	172
Omeprazole	Omeprazole	452	123
Lisinopril	Lisinopril	365	104
Hydrochlorothiazide	Hydrochlorothiazide	353	96
Simvastatin	Simvastatin	311	89
Fluoxetine Hcl	Fluoxetine Hcl	276	64
Tamsulosin Hcl	Tamsulosin Hcl	273	78
Metformin Hcl	Metformin Hcl	269	79
Metoprolol Succinate	Metoprolol Succinate	260	80
Warfarin Sodium	Warfarin Sodium	215	40
Potassium Chloride	Potassium Chloride	186	61
Eliquis	Apixaban	158	39
Gabapentin	Gabapentin	157	42
Furosemide	Furosemide	148	50
Rosuvastatin Calcium	Rosuvastatin Calcium	145	39
Metoprolol Tartrate	Metoprolol Tartrate	134	41
Pantoprazole Sodium	Pantoprazole Sodium	134	40
Zolpidem Tartrate	Zolpidem Tartrate	131	34
Meloxicam	Meloxicam	128	43
Jardiance	Empagliflozin	127	38
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	124	41
Allopurinol	Allopurinol	121	36
Atenolol	Atenolol	96	28
Alprazolam	Alprazolam	89	26
Trazodone Hcl	Trazodone Hcl	88	32
Citalopram Hbr	Citalopram Hydrobromide	85	24
Famotidine	Famotidine	82	24
Clonazepam	Clonazepam	80	22
Donepezil Hcl	Donepezil Hcl	74	18
Glipizide	Glipizide	73	26
Xarelto	Rivaroxaban	71	18
Pravastatin Sodium	Pravastatin Sodium	66	21
Albuterol Sulfate Hfa	Albuterol Sulfate	64	28
Azithromycin	Azithromycin	64	53
Carvedilol	Carvedilol	61	12
Benazepril Hcl	Benazepril Hcl	60	15
Duloxetine Hcl	Duloxetine Hcl	60	13
Lorazepam	Lorazepam	59	26
Metformin Hcl Er	Metformin Hcl	58	15
Spironolactone	Spironolactone	58	18
Synthroid	Levothyroxine Sodium	56	14
Bupropion Hcl	Bupropion Hcl	55	15
Paroxetine Hcl	Paroxetine Hcl	54	17
Escitalopram Oxalate	Escitalopram Oxalate	53	17
Memantine Hcl	Memantine Hcl	48	12
Fluticasone Propionate	Fluticasone Propionate	47	18
Prednisone	Prednisone	44	29
Ropinirole Hcl	Ropinirole Hcl	44	suppressed
Tramadol Hcl	Tramadol Hcl	41	19
Sertraline Hcl	Sertraline Hcl	39	11
Celecoxib	Celecoxib	38	suppressed
Finasteride	Finasteride	38	suppressed
Montelukast Sodium	Montelukast Sodium	38	12
Estradiol	Estradiol	37	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	35	21
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	34	suppressed
Methocarbamol	Methocarbamol	34	13
Clopidogrel	Clopidogrel Bisulfate	33	suppressed
Ozempic	Semaglutide	33	suppressed
Pregabalin	Pregabalin	33	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	32	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	32	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	31	12
Acetaminophen-Codeine	Acetaminophen With Codeine	28	suppressed
Enalapril Maleate	Enalapril Maleate	28	suppressed
Gemfibrozil	Gemfibrozil	28	suppressed
Valacyclovir	Valacyclovir Hcl	28	18
Breo Ellipta	Fluticasone/Vilanterol	27	suppressed
Glipizide Er	Glipizide	27	suppressed
Mupirocin	Mupirocin	27	22
Ezetimibe	Ezetimibe	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Methylprednisolone	Methylprednisolone	23	20
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Levetiracetam	Levetiracetam	22	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	13
Clorazepate Dipotassium	Clorazepate Dipotassium	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Diazepam	Diazepam	18	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Alendronate Sodium	Alendronate Sodium	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Temazepam	Temazepam	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	12
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	13	suppressed
Liothyronine Sodium	Liothyronine Sodium	13	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Armodafinil	Armodafinil	12	suppressed
Cefuroxime	Cefuroxime Axetil	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Valsartan	Valsartan	12	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	11	suppressed
Estradiol (Twice Weekly)	Estradiol	11	suppressed
Humalog	Insulin Lispro	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Testosterone	Testosterone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error